Pleckstrin-2 as a Prognostic Factor and Mediator of Gastric Cancer Progression

Figure 1

PLEK2 expression was elevated in gastric cancer. (a) The expression of PLEK2 mRNA in primary gastric cancer and adjacent noncancerous tissues in TCGA dataset. (b) The expression of PLEK2 mRNA in primary gastric cancer and adjacent noncancerous tissues by real-time PCR. The expression levels were normalized to those of GAPDH. (c) Representative western blots demonstrating the expression of PLEK2 protein in each of the primary gastric cancer and adjacent noncancerous tissues paired from the same patient. The expression levels were normalized to those of GAPDH. (d) The expression of PLEK2 protein in gastric cancer cell lines. GAPDH was the loading control. (e) Relative PLEK2 mRNA expression in gastric cancer cell lines. STAD: stomach adenocarcinoma; num: number; T: tumour; N: noncancerous tissues.

(a)

(b)

(c)

(d)

(e)